Increased incidence and treatment of intracranial atherosclerotic disease during mechanical thrombectomy is safe, even with an increased number of passes.

Marlon Carl MonayaoAhmed A MalikLaurie PrestonMarlon Carl MonayaoWondwossen G Tekle Ameer E Hassan

Published in: Journal of neurointerventional surgery (2021)

Patients who underwent MT with underlying ICAD had similar rates of favorable outcomes as those without, but required a higher number of device passes.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
risk factors
metabolic syndrome
adipose tissue
weight loss